Cheil Bio Co

Cheil Bio Co Gross Margin

Delisted·Feb 25, 2026

The Gross Margin of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is 23.14 %. In the previous year, Gross Margin was 19.23 % — a change of 20.34% (higher).

Gross Margin

23.14 %

YoY

20.34%

Last updated:

Gross Margin of Cheil Bio Co is 2024 23.14 % . Gross Margin of Cheil Bio Co was 2023 19.23 % . It decreases by 20.34% higher compared to the previous year.

For Cheil Bio Co, the gross margin of 23.1% is up versus 19.9% a few years ago.

The Cheil Bio Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2017
22.44 KRW
Jan 1, 2018
20.67 KRW
Jan 1, 2019
21.22 KRW
Jan 1, 2020
19.93 KRW
Jan 1, 2021
13.15 KRW
Jan 1, 2022
15.93 KRW
Jan 1, 2023
19.23 KRW
Jan 1, 2024
23.14 KRW
The Cheil Bio Co Gross Margin history
YEARGross MarginYoY
23.14 %+20.34%
19.23 %+20.75%
15.93 %+21.08%
13.15 %-34.01%
19.93 %-6.06%
21.22 %+2.66%
20.67 %-7.89%
22.44 %+21.29%
18.50 %+5.97%
17.46 %+59.81%
10.92 %+11,587.52%
0.09 %-8.74%
0.10 %-24.38%
0.14 %-14.40%
0.16 %-26.37%
0.21 %+131.61%
0.09 %-33.10%
0.14 %-28.37%
0.19 %+33.62%
0.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Gross Margin of Cheil Bio Co is 23.14 % in 2024.

Gross Margin of Cheil Bio Co changed from 19.23 % to 23.14 %, representing a 20.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Cheil Bio Co

All Key Metrics — Cheil Bio Co